Free Stipulation - District Court of Delaware - Delaware

Case 1 :04-cv-00171-GMS Document 163 Filed 12/19/2006 Page 1 of 3
IN THE UNITED STATES DISTRICT COURT
FOR THE DISTRICT OF DELAWARE
·**····· ·•···· ·· —·—— ·· ——————- — —--~—---- -—· ———- -·-· •-—· - —-———- —-—·——--·X
GLAXO GROUP LIMITED :
Piamtirr, 2
v.
: Civil Action No. O4-l7I·***
TEV A PHARMACEUTICALS USA, INC. and :
TEV A PHARMACEUTICAL INDUSTRIES :
LIMITED :
Defendants. 2
............................................................... Q,
STIPULATION AND ORDER
WHEREAS, the Honorable Kent A. Jordan has been confirmed by the United States
Senate to sit on the Third Circuit Court of Appeals; and
WHEREAS, an order construing the claims of U.S. Patent No. 5,068,249 and otherwise
ruling on the parties’ respective summary judgment motions has not been issued, which
decisions will impact and potentially limit the issues for trial; and
WHEREAS, defendants Teva Pharmaceuticals USA, Inc. and Teva Pharmaceutical
Industries Limited (collectively "Teva") have not yet received approval from the Food and Drug
Administration ("FDA") to market their generic Ranitidine Oral Solution USP, I5 mg/mL
product, as described in Abbreviated New Drug Application ("ANDA") No. 76-937 which is the
subject of this patent infringement action; and
WHEREAS, Teva does not expect to receive approval from the FDA to market its
generic Ranitidine Oral Solution USP, I5 mg/mL product as described in ANDA No. 76-937 in
the near future; and
WHEREAS, in the interests of judicial economy and the parties’ need to prepare the case
for trial in an efficient manner;
l·NY/2119334.1 _ _
DBOl:2255790.l 0>89>6·l00*

Case 1:04-cv—00171—Gl\/IS Document 163 Filed 12/19/2006 Page 2 of 3
IT IS HEREBY STIPULATED AND AGREED, by and between the undersigned
counsel for Teva and plaintiff Glaxo Group Limited, subject to the approval of the Court, that the
remaining pretrial and trial deadlines will be provisionally extended by 60 days or until such
time as this case is reassigned to another United States District Judge and a final trial schedule
entered, as follows:
1. the Final Pretrial Order will be filed with the Court on March 5, 2007;
2. the Pretrial Conference will take place on April __, 2007; and
3. Trial in this matter will begin on , 2007.
Dated; December 19, 2006 Dated: December I9, 2006
For Plaintiff GLAXO GROUP LIMITED For Defendants TEVA
PHARMACEUTICALS USA, INC. and
TEVA PHARMACEUTICAL
INDUSTRIES LIMITED
By:__/s/ Francis DiGiovanni__ By:
Francis DiGiovanni (#3 1 89) Jo W. Ingersoll (# 088)
CONNOLLY BOV E LODGE Karen E. Keller (#4489)
& HUTZ LLP YOUNG CONAWAY STARGATT
The Nemours Building & TAYLOR, LLP
1007 North Orange Street The Brandywine Building
P.O. Box 2207 1000 West Street, 17th Floor
Wilmington, DE I9899-2207 P.O. Box 391
(302) 888-6316 Wilmington, DE 19899-0391
(302) 571-6600
OF COUNSEL: OF COUNSEL:
Brian P. Murphy Mark D. Schuman
Thomas J. Puppa Jeffrey C. Brown
Bryan J. Vogel MERCHANT & GOULD
Oren D. Langer 3200 IDS Center
MORGAN, LEWIS & BOCKIUS LLP 80 South 8th Street
101 Park Avenue Minneapolis, MN 55402
New York, NY 10178-0060 (612) 332-5300
(212) 309-6000
Attorneys f0r· Defendcmts Teva
AttortzeysforP/c1im‘i;j'G/czxo Grozqa P/iarmczceuticcz/s USA, [nc. and T eva
Limited Plmriizctceutical Industries Limited
oa0i;22ssi90.i 2 0589561004

Case 1:04-cv—00171—G|\/IS Document 163 Filed 12/19/2006 Page 3 013
SO ORDERED this ___ day ef , 20____.
UNITED STATES DISTRICT JUDGE
DBOl:2255790.l 3 0ss9s6.10o4

Case 1:04-cv-00171-GMS

Document 163

Filed 12/19/2006

Page 1 of 3

Case 1:04-cv-00171-GMS

Document 163

Filed 12/19/2006

Page 2 of 3

Case 1:04-cv-00171-GMS

Document 163

Filed 12/19/2006

Page 3 of 3